PeptiDream Inc.
4587 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 川崎市川崎区殿町三丁目２５番２３号
- Website:
- https://www.peptidream.com/en/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
PeptiDream Inc. is a pioneering Japanese company dedicated to revolutionizing drug discovery through its innovative peptide-based therapeutics. Positioned as a "Drug Discovery Powerhouse," PeptiDream focuses on the development of transformational medicines by leveraging its proprietary Peptide Discovery Platform System (PDPS). With a commitment to advancing the peptide drug discovery ecosystem, the company collaborates with partners worldwide to enhance its research and development capabilities. PeptiDream excels in various critical disciplines, including discovery biology, medicinal chemistry, structural biology, bioinformatics, molecular modeling, and pharmacological profiling, making it a global leader in the field. Through its expertise and cutting-edge technology, PeptiDream aims to shape the future of healthcare.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-03-28 08:48 |
Internal Control over Financial Reporting
内部統制報告書－第19期(2024/01/01－2024/12/31)
|
Japanese | 23.4 KB | |
| 2025-03-28 08:47 |
Annual Report
有価証券報告書－第19期(2024/01/01－2024/12/31)
|
Japanese | 3.2 MB | |
| 2025-03-28 08:47 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2025-03-28 08:45 |
Inside Information Statement
臨時報告書
|
Japanese | 23.6 KB | |
| 2024-09-25 09:45 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2024-09-25 09:35 |
Regulatory News Service
訂正有価証券報告書－第18期(2023/01/01－2023/12/31)
|
Japanese | 1.4 MB | |
| 2024-08-09 08:29 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2024-08-09 08:28 |
Interim Report
半期報告書－第19期(2024/01/01－2024/12/31)
|
Japanese | 650.4 KB | |
| 2024-05-15 08:31 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2024-05-15 08:30 |
Quarterly Report
四半期報告書－第19期第1四半期(2024/01/01－2024/03/31)
|
Japanese | 540.7 KB | |
| 2024-04-01 08:30 |
Prospectus
有価証券届出書（参照方式）
|
Japanese | 95.3 KB | |
| 2024-03-28 07:53 |
Inside Information Statement
臨時報告書
|
Japanese | 22.4 KB | |
| 2024-03-28 07:40 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2024-03-28 07:39 |
Internal Control over Financial Reporting
内部統制報告書－第18期(2023/01/01－2023/12/31)
|
Japanese | 23.4 KB | |
| 2024-03-28 07:38 |
Annual Report
有価証券報告書－第18期(2023/01/01－2023/12/31)
|
Japanese | 2.8 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
AnGes, Inc. | Japan | 4563 |